Docket Room
HB 32·KY·house

AN ACT relating to coverage for epinephrine devices.

In CommitteeFiled Jan 6, 2026
Latest Action

to Banking & Insurance (H)

Jan 13, 2026

Summary

The bill forces all health benefit plans in Kentucky to provide at least two medically necessary epinephrine devices to each enrollee annually and caps any cost‑sharing for those devices at $100 per year. It also adds reporting and cost‑sharing rules for qualified health plans, and ties the new requirement to Medicaid managed‑care plans. The goal is to make life‑saving allergy treatment more affordable and accessible.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 32 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice